Professional Documents
Culture Documents
HYPERGLYCAEMIA
The Pancreas and Its Functions
Acute Chronic
Hypoglycaemia Neiropathy
Hyperosmolar
Retinopathy
hyperglycaemic state
Vsculopathy
• Neuro-glycopenic
Plasma Glucose < 50 mg/dL (2.8 mmol/L)
Slurred speech Cognitive impairment Inattention and confusion
Focal neurologic deficits Seizures Behavioral/ Irritability/ Sudden moodiness
Change in personality Lack of coordination
Severe and prolonged hypoglycemia LOC/Coma Irreversible brain injury
Hyperosmolar hyperglycemic state (HHS)
• is a complication of diabetes mellitus (predominantly type 2) in which
high blood sugars cause severe dehydration, increases in osmolarity
(relative concentration of solute) and a high risk of complications,
coma and death.
• Older names for HHS were hyperosmolar nonketotic coma (HONC),
hyperosmolar hyperglycemic nonketotic coma, etc…
Name changed to HHS in order to present the alterations in the mental
status that occur without coma. Coma is found in fewer than 20% of
patients with HHS
Pathophysiology
there is enough insulin to prevent acidosis and formation of ketone
bodies at the cellular level, but there is not enough insulin to facilitate
transportation of all the glucose into the cells.
: glucose molecules accumulate in the blood stream,
causing serum hyper osmolality with resultant osmotic
diuresis and simultaneous loss of electrolytes, most
notably potassium, sodium, and phosphate.
• Patients may lose up
to 25% of their total
body water. Fluids are
pulled from individual
body cells by
increasing serum
hyper osmolality and
extracellular fluid
loss, causing
intracellular
dehydration and body
cell shrinkage.
Symptoms of HHC
• The patient with HHC has severe hyperglycemia and azotemia without
ketoacidosis. The intravascular volume is contracted, and the patient shows
signs and symptoms of hypovolemia and severe dehydration.
• Both diffuse and focal central nervous system deficits may occur.
• These may include hallucinations, aphasia, nystagmus, hemianopsia,
hemiplegia, hemi sensory deficits, and focal or grand mal seizures. Coma
may ensue
• As extracellular volume decreases……. blood viscosity increases, causing
slowing of blood flow Thromboemboli are common (increased blood
viscosity, enhanced platelet aggregation and adhesiveness, and possibly
patient’s immobility).
• Cardiac workload is increased and may lead to MI(myocardial
infarction)
• Renal blood flow is decreased, potentially resulting in renal
impairment or failure.
• Stroke may result from thromboemboli or decreased cerebral
perfusion.
• Mortality rate of HHS ranges from 10%-50%, which is higher than that
of DKA (1.2%-9%).
• The cardinal symptoms of polyuria and polydipsia are noted first but
may be ignored by older persons or their families.
DIABETIC KETOACIDOSIS (DKA)
• A state of absolute or relative insulin deficiency aggravated by
ensuing hyperglycemia, dehydration, and acidosis-producing
derangements in intermediary metabolism, including production of
serum acetone.
• Can occur in both Type I Diabetes and Type II Diabetes – In type II
diabetics with insulin deficiency/dependence
• The presenting symptom for ~ 25% of Type I Diabetics.
• Diabetic KetoAcidosis (DKA) 1. 160,000 Admissions to private
hospitals/year 2. Cost = over 1 billion $ annually 3. 65% = <19 years
old 4. Main cause of death in children with diabetes (approximately
85%) 5. Cerebral edema in 69%
• Why do ketones develop?
No carbohydrate intake • fasting • gastroenteritis • Atkins diet,
neonates fed high-fat milk Prolonged exercise, pregnancy Lack of insulin
activity • onset of diabetes (insufficient secretion) • interruption of
insulin delivery in established pt Increase in insulin resistance •
infection, illness, surgery, stress Alcohol, salicylate ingestion, inborn
metabolic errors
• Causes of DKA/HHS
Stressful precipitating event that results in increased
catecholamines, cortisol, glucagon. – Infection (pneumonia, UTI) –
Alcohol, drugs – Stroke – Myocardial Infarction – Pancreatitis – Trauma
– Medications (steroids, thiazide diuretics) – Non-compliance with
insulin